# Southwest Health Corp. – FDA Inspection, Mar 31, 2015

Source: https://www.keypedia.com/records/fda_inspections/southwest-health-corp/2dc8ecdc-8fc3-4f2f-8d31-dcf5337f27b0
Source feed: FDA_Inspections

> FDA inspection 919742 of Southwest Health Corp., March 31, 2015. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 919742
- Company Name: Southwest Health Corp.
- Inspection Date: 2015-03-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1013479 - 2017-05-19
- [FDA Inspection 821394 - 2013-03-18](https://www.keypedia.com/records/fda_inspections/southwest-health-corp/82d2f343-0a2f-4e9e-aad0-aaa4c084491b)
- [FDA Inspection 723201 - 2011-05-04](https://www.keypedia.com/records/fda_inspections/southwest-health-corp/e9272e32-7f13-42d9-9a6c-7c3bbfd80a3e)
- [FDA Inspection 629666 - 2009-10-29](https://www.keypedia.com/records/fda_inspections/southwest-health-corp/239578f1-9cd6-47bc-895a-53db9369061f)
- FDA Inspection 566163 - 2009-02-26

Company: https://www.keypedia.com/companies/southwest-health-corp/54cd2a85-9137-448e-8219-eaaa0e4b7ed6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d